LncRNA PKD2-2-3对肺腺癌细胞增殖、克隆形成、迁移及侵袭能力的影响

贾利晴; 葛小路; 姜琳; 周晓燕

doi:10.19401/j.cnki.1007-3639.2023.08.001

您当前的位置：

首页 >

文章列表页 >

LncRNA PKD2-2-3对肺腺癌细胞增殖、克隆形成、迁移及侵袭能力的影响

论著 | 更新时间：2025-12-31

- LncRNA PKD2-2-3对肺腺癌细胞增殖、克隆形成、迁移及侵袭能力的影响
- Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
- 中国癌症杂志 2023年33卷第8期页码：717-725
- 作者机构：
  
  1. 复旦大学附属肿瘤医院病理科，复旦大学上海医学院肿瘤学系，复旦大学病理研究所，上海 200032
  2. 上海市第一人民医院疑难疾病精准研究中心，上海 201620
- 作者简介：
  
  [ "贾利晴（ORCID：0000-0003-1734-6043），硕士。" ]
  周晓燕（ORCID：0000-0001-5999-7237），主任医师，教授。
- 基金信息：
  
  国家自然科学基金(82002424)
- DOI：10.19401/j.cnki.1007-3639.2023.08.001
  中图分类号： R734.2
- 收稿：2023-05-01，
  
  修回：2023-07-05，
  
  纸质出版：2023-08-30
- 稿件说明：
移动端阅览
贾利晴, 葛小路, 姜琳, 等. LncRNA PKD2-2-3对肺腺癌细胞增殖、克隆形成、迁移及侵袭能力的影响[J]. 中国癌症杂志, 2023,33(8):717-725.

Liqing JIA, Xiaolu GE, Lin JIANG, et al. Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma[J]. China Oncology, 2023, 33(8): 717-725.
贾利晴, 葛小路, 姜琳, 等. LncRNA PKD2-2-3对肺腺癌细胞增殖、克隆形成、迁移及侵袭能力的影响[J]. 中国癌症杂志, 2023,33(8):717-725. DOI： 10.19401/j.cnki.1007-3639.2023.08.001.

Liqing JIA, Xiaolu GE, Lin JIANG, et al. Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma[J]. China Oncology, 2023, 33(8): 717-725. DOI： 10.19401/j.cnki.1007-3639.2023.08.001.

摘要

背景与目的：

长链非编码RNA（long non-coding RNA，lncRNA）在肺腺癌患者中异常表达，与肿瘤的发生、发展和化疗耐药密切相关。本研究旨在探讨lncRNA蛋白激酶D2（lncRNA

PKD2-2-3）在肺腺癌发生、发展过程中发挥的生物学功能，验证lncRNA PKD2-2-3对肺腺癌细胞增殖、克隆形成、迁移和侵袭的影响。

方法：

基于Affymetrix人类基因芯片转录组阵列2（Affymetrix® GeneChip Human Transcriptome Array 2.0，HTA2.0）分析3对肺腺癌组织及癌旁组织，寻找在肺腺癌组织中高表达的lncRNA，其中lncRNA PKD2-2-3的表达差异最大。利用基因表达综合数据库（Gene Expression Omnibus，GEO）中GSE19188和GSE30219的数据分析lncRNA PKD2-2-3在肺腺癌组织中的表达和对患者预后的影响。通过实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）检测lncRNA PKD2-2-3在细胞系（HBE、A549、PC9）中的表达情况。在A549和PC9两种细胞系中使用siRNA干扰技术敲低lncRNA PKD2-2-3的表达，通过细胞计数试剂盒-8（cell counting kit-8，CCK-8）实验和克隆形成实验检测lncRNA PKD2-2-3表达对肺腺癌细胞增殖和克隆形成能力的影响；划痕实验和transwell实验分别检测lncRNA PKD2-2-3表达对肺腺癌细胞迁移和侵袭的影响。蛋白质印迹法（Western blot）检测敲低lncRNA PKD2-2-3表达后对上皮-间质转化（epithelial-mesenchymal transition，EMT）相关蛋白E-钙黏蛋白（E-cadherin）和N-钙黏蛋白（N-cadherin）表达水平的影响。皮下移植瘤模型探究lncRNA PKD2-2-3在体内对肺腺癌细胞增殖的影响。

结果：

LncRNA PKD2-2-3在肺腺癌组织中呈高表达，且高表达的患者预后较差。对比正常气管上皮永生化细胞HBE，lncRNA PKD2-2-3在肺腺癌细胞系A549和PC9中高表达，敲低lncRNA PKD2-2-3的表达抑制肺腺癌细胞的增殖、克隆形成、迁移和侵袭能力。Western blot结果显示，敲低lncRNA PKD2-2-3后，E-cadherin表达水平升高，N-cadherin表达水平降低。皮下移植瘤实验表明，在体内lncRNA PKD2-2-3敲低后抑制肺腺癌的生长。

结论：

ncRNA PKD2-2-3在肺腺癌组织中上调表达，且与患者的不良预后相关，lncRNA PKD2-2-3的高表达促进肺腺癌细胞的增殖、克隆形成、迁移和侵袭能力，体内外实验表明lncRNA PKD2-2-3的表达与肺腺癌的EMT过程密切相关。

Abstract

Background and purpose:

Long non-coding RNA (lncRNA) is abnormally expressed in lung adenocarcinoma patients

and closely related to tumor occurrence

development and chemotherapy resistance. In this study

we mainly investigated the biological function of lncRNA PKD2-2-3 and verified its effect on the proliferation

colony formation

migration and invasion in lung adenocarcinoma.

Methods:

Three pairs of lung adenocarcinoma tissues and adjacent tissues were analyzed based on expression profiling Affymetrix® GeneChip Human Transcriptome Array 2.0 (HTA2.0)

and we focused on lncRNA PKD2-2-3 that showed most significant difference between lung adenocarcinoma issues and adjacent tissues. Besides

we found the upre

gulated expression of lncRNA PKD2-2-3 in lung adenocarcinoma tissues and suggested the relation of lncRNA PKD2-2-3 expression with prognosis by using GSE19188 and GSE30219 data in Gene Expression Omnibus (GEO) database. Real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) was used to detect the expression of lncRNA PKD2-2-3 in cell lines including HBE

A549 and PC9. After using siRNAs to decrease the expression of lncRNA PKD2-2-3 in A549 and PC9

we detected cell proliferation and colony formation by cell counting kit-8 (CCK-8) assay and colony formation assay. Effects of lncRNA PKD2-2-3 on migration and invasion in lung adenocarcinoma cells were detected by wound-healing assay and transwell assay

respectively. Moreover

we detected expression levels of E-cadherin and N-cadherin that were epithelial-mesenchymal transition (EMT) related genes by Western blot. The effect of lncRNA PKD2-2-3 on the formation and growth of lung adenocarcinoma

in vivo

was verified by subcutaneous transplantation tumor model.

Results:

LncRNA PKD2-2-3 was highly expressed in lung adenocarcinoma tissue

and was positively associated with poor prognosis of lung adenocarcinoma patients. Compared with human bronchial epithelial cells (HBE)

lncRNA PKD2-2-3 was overexpressed in A549 and PC9. The proliferation

colony formation

migration and invasion of lung adenocarcinoma cells were significantly inhibited when decreasing the expression level of lncRNA PKD2-2-3. Western blot also showed that the expression level of E-cadherin was increased

while the level of N-cadherin was decreased after lncRNA PKD2-2-3 knockdown. Subcutaneous tumor transplantation experiments showed that lncRNA PKD2-2-3 knockdown inhibited the growth of lung adenocarcinoma

in vivo

Conclusion:

LncRNA PKD2-2-3 expression was upregulated in lung adenocarcinoma tissues

and it was associated with poor prognosis of lung adenocarcinoma patients. Overexpression of lncRNA PKD2-2-3 promoted the proli

feration

colony formation

migration and invasion of lung adenocarcinoma cells. LncRNA PKD2-2-3 level was closely related to EMT process in lung adenocarcinoma

in vitro

and

in vivo

关键词

Keywords

references

SIEGEL R , MA J M , ZOU Z H , et al . Cancer statistics, 2023 [J ] . CA A Cancer J Clin , 2023 , 73 ( 1 ): 17 - 48 . DOI: 10.3322/caac.v73.1 http://doi.org/10.3322/caac.v73.1 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/73/1 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/73/1

CHEN P X , LIU Y H , WEN Y K , et al . Non-small cell lung cancer in China [J ] . Cancer Commun (Lond) , 2022 , 42 ( 10 ): 937 - 970 .

CHI Y J , WANG D , WANG J P , et al . Long non-coding RNA in the pathogenesis of cancers [J ] . Cells , 2019 , 8 ( 9 ): 1015 . DOI: 10.3390/cells8091015 http://doi.org/10.3390/cells8091015 https://www.mdpi.com/2073-4409/8/9/1015 https://www.mdpi.com/2073-4409/8/9/1015

GE X L , LI G Y , JIANG L , et al . Long non-coding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis [J ] . Oncogene , 2019 , 38 ( 16 ): 3061 - 3076 . DOI: 10.1038/s41388-018-0645-x http://doi.org/10.1038/s41388-018-0645-x

JIANG M , QI F , ZHANG K , et al . MARCKSL1-2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b [J ] . Mol Cancer , 2022 , 21 ( 1 ): 150 . DOI: 10.1186/s12943-022-01605-w http://doi.org/10.1186/s12943-022-01605-w

ZHANG L , MA D L , LI F J , et al . Lnc-PKD2-2-3/miR-328/GPAM ceRNA network induces cholangiocarcinoma proliferation, invasion and 5-FU chemoresistance [J ] . Front Oncol , 2022 , 12 : 871281 . DOI: 10.3389/fonc.2022.871281 http://doi.org/10.3389/fonc.2022.871281 https://www.frontiersin.org/articles/10.3389/fonc.2022.871281/full https://www.frontiersin.org/articles/10.3389/fonc.2022.871281/full

QIU G C , MA D L , LI F J , et al . Lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma [J ] . Int J Oncol , 2019 , 55 ( 1 ): 45 - 58 . DOI: 10.3892/ijo.2019.4798 http://doi.org/10.3892/ijo.2019.4798

JIA L Q , GE X L , DU C , et al . EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling [J ] . Br J Cancer , 2021 , 124 ( 7 ): 1301 - 1311 . DOI: 10.1038/s41416-020-01250-4 http://doi.org/10.1038/s41416-020-01250-4

HOU J , AERTS J , DEN HAMER B , et al . Gene expression-based classification of non-small cell lung carcinomas and survival prediction [J ] . PLoS One , 2010 , 5 ( 4 ): e10312.

ROUSSEAUX S , DEBERNARDI A , JACQUIAU B , et al . Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers [J ] . Sci Transl Med , 2013 , 5 ( 186 ): 186 ra66.

LI T F , ZHOU S , YANG Y , et al . LncRNA MNX1-AS1: a novel oncogenic propellant in cancers [J ] . Biomedecine Pharmacother , 2022 , 149 : 112801 .

FARZANEH M , GHASEMIAN M , GHAEDRAHMATI F , et al . Functional roles of lncRNA-TUG1 in hepatocellular carcinoma [J ] . Life Sci , 2022 , 308 : 120974 . DOI: 10.1016/j.lfs.2022.120974 http://doi.org/10.1016/j.lfs.2022.120974 https://linkinghub.elsevier.com/retrieve/pii/S0024320522006749 https://linkinghub.elsevier.com/retrieve/pii/S0024320522006749

FARZANEH M , NAJAFI S , ANBIYAEE O , et al . LncRNA MALAT1-related signaling pathways in osteosarcoma [J ] . Clin Transl Oncol , 2023 , 25 ( 1 ): 21 - 32 . DOI: 10.1007/s12094-022-02876-x http://doi.org/10.1007/s12094-022-02876-x

ZHANG Y X , YUAN J , GAO Z M , et al . LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway [J ] . Eur Rev Med Pharmacol Sci , 2018 , 22 ( 2 ): 443 - 449 .

TIAN H , LIAN R , LI Y , et al . AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent vimentin degradation [J ] . Nat Commun , 2020 , 11 ( 1 ): 5127 . DOI: 10.1038/s41467-020-18929-0 http://doi.org/10.1038/s41467-020-18929-0

HASHEMI M , MOOSAVI M S , ABED H M , et al . Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy [J ] . Pharmacol Res , 2022 , 184 : 106418 . DOI: 10.1016/j.phrs.2022.106418 http://doi.org/10.1016/j.phrs.2022.106418 https://linkinghub.elsevier.com/retrieve/pii/S1043661822003632 https://linkinghub.elsevier.com/retrieve/pii/S1043661822003632

浏览量

2512

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

GOLM1调控PI3K/AKT/mTOR信号转导通路促进肺腺癌细胞增殖、侵袭和迁移的机制研究

HER-2通过ZEB1促进乳腺癌细胞上皮间质转化

下调Rab11基因对宫颈癌HeLa/SiHa细胞侵袭迁移的影响及机制探讨

SEC14L1P1对口腔鳞状细胞癌细胞增殖和迁移的影响

长链非编码RNA FLJ30679对口腔鳞状细胞癌细胞增殖和迁移的影响